Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Accession codes
References
Jackson, R. C., Weber, G. & Morris, H. P. IMP dehydrogenase, an enzyme linked with proliferation and malignancy. Nature 256, 331–333 (1975).
Shu, Q. N. & Nair, V. Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery. Med. Res. Rev. 28, 219–232 (2008).
Hood, K. A. & Zarembski, D. G. Mycophenolate mofetil: a unique immuno-suppressive agent. Am. J. Health Syst. Pharm. 54, 285–294 (1997).
Ishikawa, H. Mizoribine and mycophenolate mofetil. Curr. Med. Chem. 6, 575–597 (1999).
Jain, J. et al. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5′-monophosphate dehydrogenase inhibitor. J. Pharmacol. Exp. Ther. 302, 1272–1277 (2002).
Floryk, D. & Thompson, T. C. Antiproliferative effects of AVN944, a novel inosine 5-monophosphate dehydrogenase inhibitor, in prostate cancer cells. Int. J. Cancer 123, 2294–2302 (2008).
Arai, M. et al. Halicyclamine A, a marine spongean alkaloid as a lead for anti-tuberculosis agent. Bioorg. Med. Chem. 16, 6732–6769 (2008).
Franklin, T. J., Jacobs, V., Bruneau, P. & Ple, P. Glucuronidation by human colorectal adenocarcinoma cells as a mechanism of resistance to mycophenolic acid. Adv. Enz. Regul. 35, 91–100 (1995).
Jones, C. E., Taylor, P. J., McEwan, A. G. & Hanson, G. R. Spectroscopic characterization of copper (II) binding to the immunosuppressive drug mycophenolic acid. J. Am. Chem. Soc. 128, 9378–9386 (2006).
Habib, E. et al. Mycophenolic derivatives from Eupenicilliumparvum. J. Nat. Prod. 71, 1915–1918 (2008).
Magasanik, B., Moyed, H. S. & Gehring, L. B. Enzymes essential for the biosynthesis of nucleic acid guanine; inosine 5′-phosphate dehydrogenase of Aerobacter aerogenes. J. Biol. Chem. 226, 339–350 (1957).
Domhan, S. et al. Molecular mechanisms of the antiangiogenic and antitumor effects of mycophenolic acid. Mol. Cancer Ther. 7, 1656–1668 (2008).
Batovska, D. I. et al. Hydroxamic acid derivatives of mycophenolic acid inhibit histone deacetylase at the cellular level. Biosci. Biotechnol. Biochem. 72, 2623–2631 (2008).
Hideaki, U. et al. Mycophenolic acid inhibits syncytium formation accompanied by reduction of gp120 expression. J. Antibiot. 58, 514–518 (2005).
Ubukata, M. et al. Mycophenolic acid as a latent agonist of PPARgamma. Bioorg. Med. Chem. Lett. 17, 4767–4770 (2007).
Gulyas, E. et al. Method for producing impurity level in mycophenolic acid fermentation. US 20080254520 Oct. 16, (2008).
Acknowledgements
The Syngenta Postgraduate Studentship awarded to Xinhua Lu (2008-Hebei Medical University-Syngenta-2) is appreciated. We thank the colleagues from the New Drug Research and Development Center, North China Pharmaceutical Group Ltd for their kindly assistance especially Mr Dong Guo and Mrs Shiqing Zhu for NMR and MS measurements and Mr Yeying Li, Mrs Xiaolan Cui and Ying Shi for the fungus identification and fermentation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lu, X., Zheng, Z., Zhang, H. et al. Two new members of mycophenolic acid family from Penicillium brevicompactum Dierckx. J Antibiot 62, 527–529 (2009). https://doi.org/10.1038/ja.2009.54
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ja.2009.54
